WallStreetZenWallStreetZen

NASDAQ: PDEX
Pro Dex Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

PDEX past earnings growth

How has PDEX's earnings growth performed historically?
Company
-22.53%
Industry
27.71%
Market
72.61%
PDEX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PDEX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PDEX's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PDEX past revenue growth

How has PDEX's revenue growth performed historically?
Company
9.03%
Industry
7.53%
Market
17.55%
PDEX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PDEX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PDEX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PDEX earnings and revenue history

Current Revenue
$48.2M
Current Earnings
$5.0M
Current Profit Margin
10.4%

PDEX Return on Equity

Current Company
16.6%
Current Industry
11.1%
Current Market
188%
PDEX's Return on Equity (16.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PDEX announces earnings.

PDEX Return on Assets

Current Company
10%
Current Industry
7.2%
PDEX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PDEX Return on Capital Employed

Current Company
17.61%
Current Industry
9.7%
PDEX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PDEX vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PDEX$48.24M$8.34M$5.00M+14.00%+13.76%
BNGO$36.12M-$213.34M-$232.49M+24.65%N/A
MLSS$9.83M-$6.90M-$6.93M+0.42%N/A
POCI$19.22M-$1.29M-$1.72M+29.71%N/A
RVP$43.60M-$1.24M-$7.24M+5.55%N/A
View Top Medical Stocks

PDEX earnings dates

Next earnings date
May 2, 2024

Pro Dex Earnings & Revenue FAQ

What were PDEX's earnings last quarter?

On Invalid Date, Pro Dex (NASDAQ: PDEX) reported Q4 2023 earnings per share (EPS) of $0.14, up 81.82% year over year. Total Pro Dex earnings for the quarter were $500.00 thousand. In the same quarter last year, Pro Dex's earnings per share (EPS) was $0.77.

If you're new to stock investing, here's how to buy Pro Dex stock.

What was PDEX's earnings growth in the past year?

As of Q2 2024, Pro Dex's earnings has grown -22.53% year over year. This is 50.23 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 27.71%. Pro Dex's earnings in the past year totalled $5.00 million.

What is PDEX's earnings date?

Pro Dex's earnings date is Invalid Date. Add PDEX to your watchlist to be reminded of PDEX's next earnings announcement.

What was PDEX's revenue last quarter?

On Invalid Date, Pro Dex (NASDAQ: PDEX) reported Q4 2023 revenue of $12.59 million up 11.58% year over year. In the same quarter last year, Pro Dex's revenue was $11.28 million.

What was PDEX's revenue growth in the past year?

As of Q2 2024, Pro Dex's revenue has grown 9.03% year over year. This is 1.5 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 7.53%. Pro Dex's revenue in the past year totalled $48.24 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.